▶ 調査レポート

静脈内溶液(コロイド)の世界市場レポート2020

• 英文タイトル:Global Intravenous Solutions (Colloids) Sales Market Report 2020

が調査・発行した産業分析レポートです。静脈内溶液(コロイド)の世界市場レポート2020 / Global Intravenous Solutions (Colloids) Sales Market Report 2020 / MRC2102QY7445資料のイメージです。• レポートコード:MRC2102QY7445
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、134ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の静脈内溶液(コロイド)市場について種類別(末梢静脈栄養、総非経口栄養)、用途別(病院&クリニック、外来、在宅ケア)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・静脈内溶液(コロイド)市場の概要
・世界の主要地域別静脈内溶液(コロイド)市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の静脈内溶液(コロイド)市場規模2015-2026:種類別(末梢静脈栄養、総非経口栄養)
・世界の静脈内溶液(コロイド)市場規模2015-2026:用途別(病院&クリニック、外来、在宅ケア)
・静脈内溶液(コロイド)の米国市場規模2015-2020
・静脈内溶液(コロイド)のヨーロッパ市場規模2015-2020
・静脈内溶液(コロイド)の中国市場規模2015-2020
・静脈内溶液(コロイド)の日本市場規模2015-2020
・静脈内溶液(コロイド)の東南アジア市場規模2015-2020
・静脈内溶液(コロイド)のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・静脈内溶液(コロイド)の製造コスト分析
・販売チャネル、流通業者、顧客
・静脈内溶液(コロイド)の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Intravenous Solutions (Colloids) Market
The global Intravenous Solutions (Colloids) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Intravenous Solutions (Colloids) Scope and Market Size
The global Intravenous Solutions (Colloids) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Solutions (Colloids) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Intravenous Solutions (Colloids) market is segmented into
Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Segment by Application, the Intravenous Solutions (Colloids) market is segmented into
Hospital & Clinics
Ambulatory
Home Care

The Intravenous Solutions (Colloids) market is analysed and market size information is provided by regions (countries). Segment by Application, the Intravenous Solutions (Colloids) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Intravenous Solutions (Colloids) Market Share Analysis
Intravenous Solutions (Colloids) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous Solutions (Colloids) business, the date to enter into the Intravenous Solutions (Colloids) market, Intravenous Solutions (Colloids) product introduction, recent developments, etc.

The major vendors covered:
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.

レポート目次

1 Intravenous Solutions (Colloids) Market Overview
1.1 Intravenous Solutions (Colloids) Product Scope
1.2 Intravenous Solutions (Colloids) Segment by Type
1.2.1 Global Intravenous Solutions (Colloids) Sales by Type (2020-2026)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Solutions (Colloids) Segment by Application
1.3.1 Global Intravenous Solutions (Colloids) Sales Comparison by Application (2020-2026)
1.3.2 Hospital & Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Intravenous Solutions (Colloids) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Intravenous Solutions (Colloids) Sales Growth Rate (2015-2026)
1.4.2 Global Intravenous Solutions (Colloids) Revenue and Growth Rate (2015-2026)
1.4.3 Global Intravenous Solutions (Colloids) Price Trends (2015-2026)

2 Intravenous Solutions (Colloids) Estimate and Forecast by Region
2.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Intravenous Solutions (Colloids) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020)
2.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2015-2020)
2.3 Global Intravenous Solutions (Colloids) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Intravenous Solutions (Colloids) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Intravenous Solutions (Colloids) Estimates and Projections (2015-2026)
2.4.2 Europe Intravenous Solutions (Colloids) Estimates and Projections (2015-2026)
2.4.3 China Intravenous Solutions (Colloids) Estimates and Projections (2015-2026)
2.4.4 Japan Intravenous Solutions (Colloids) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Intravenous Solutions (Colloids) Estimates and Projections (2015-2026)
2.4.6 India Intravenous Solutions (Colloids) Estimates and Projections (2015-2026)
3 Global Intravenous Solutions (Colloids) Competition Landscape by Players
3.1 Global Top Intravenous Solutions (Colloids) Players by Sales (2015-2020)
3.2 Global Top Intravenous Solutions (Colloids) Players by Revenue (2015-2020)
3.3 Global Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions (Colloids) as of 2019)
3.4 Global Intravenous Solutions (Colloids) Average Price by Company (2015-2020)
3.5 Manufacturers Intravenous Solutions (Colloids) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Intravenous Solutions (Colloids) Players (Opinion Leaders)
4 Global Intravenous Solutions (Colloids) Market Size by Type
4.1 Global Intravenous Solutions (Colloids) Historic Market Review by Type (2015-2020)
4.1.1 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
4.1.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2015-2020)
4.1.3 Global Intravenous Solutions (Colloids) Price by Type (2015-2020)
4.2 Global Intravenous Solutions (Colloids) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Intravenous Solutions (Colloids) Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Type (2021-2026)
4.2.3 Global Intravenous Solutions (Colloids) Price Forecast by Type (2021-2026)
5 Global Intravenous Solutions (Colloids) Market Size by Application
5.1 Global Intravenous Solutions (Colloids) Historic Market Review by Application (2015-2020)
5.1.1 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
5.1.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2015-2020)
5.1.3 Global Intravenous Solutions (Colloids) Price by Application (2015-2020)
5.2 Global Intravenous Solutions (Colloids) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Intravenous Solutions (Colloids) Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous Solutions (Colloids) Price Forecast by Application (2021-2026)

6 United States Intravenous Solutions (Colloids) Market Facts & Figures
6.1 United States Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
6.2 United States Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
6.3 United States Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)

7 Europe Intravenous Solutions (Colloids) Market Facts & Figures
7.1 Europe Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
7.2 Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
7.3 Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)

8 China Intravenous Solutions (Colloids) Market Facts & Figures
8.1 China Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
8.2 China Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
8.3 China Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)

9 Japan Intravenous Solutions (Colloids) Market Facts & Figures
9.1 Japan Intravenous Solutions (Colloids) Sales Market Share by Company (3015-3030)
9.2 Japan Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
9.3 Japan Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)

10 Southeast Asia Intravenous Solutions (Colloids) Market Facts & Figures
10.1 Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)

11 India Intravenous Solutions (Colloids) Market Facts & Figures
11.1 India Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
11.2 India Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
11.3 India Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Intravenous Solutions (Colloids) Business
12.1 ICU Medical Inc.
12.1.1 ICU Medical Inc. Corporation Information
12.1.2 ICU Medical Inc. Business Overview
12.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Products Offered
12.1.5 ICU Medical Inc. Recent Development
12.2 B. Braun Melsungen AG
12.2.1 B. Braun Melsungen AG Corporation Information
12.2.2 B. Braun Melsungen AG Business Overview
12.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Products Offered
12.2.5 B. Braun Melsungen AG Recent Development
12.3 Fresenius Kabi AG
12.3.1 Fresenius Kabi AG Corporation Information
12.3.2 Fresenius Kabi AG Business Overview
12.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Products Offered
12.3.5 Fresenius Kabi AG Recent Development
12.4 Baxter
12.4.1 Baxter Corporation Information
12.4.2 Baxter Business Overview
12.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Baxter Intravenous Solutions (Colloids) Products Offered
12.4.5 Baxter Recent Development
12.5 Amanta Healthcare
12.5.1 Amanta Healthcare Corporation Information
12.5.2 Amanta Healthcare Business Overview
12.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Products Offered
12.5.5 Amanta Healthcare Recent Development
12.6 Terumo Medical Corporation
12.6.1 Terumo Medical Corporation Corporation Information
12.6.2 Terumo Medical Corporation Business Overview
12.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Products Offered
12.6.5 Terumo Medical Corporation Recent Development
12.7 Grifols S.A.
12.7.1 Grifols S.A. Corporation Information
12.7.2 Grifols S.A. Business Overview
12.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Grifols S.A. Intravenous Solutions (Colloids) Products Offered
12.7.5 Grifols S.A. Recent Development

13 Intravenous Solutions (Colloids) Manufacturing Cost Analysis
13.1 Intravenous Solutions (Colloids) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Solutions (Colloids)
13.4 Intravenous Solutions (Colloids) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Intravenous Solutions (Colloids) Distributors List
14.3 Intravenous Solutions (Colloids) Customers

15 Market Dynamics
15.1 Intravenous Solutions (Colloids) Market Trends
15.2 Intravenous Solutions (Colloids) Opportunities and Drivers
15.3 Intravenous Solutions (Colloids) Market Challenges
15.4 Intravenous Solutions (Colloids) Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Intravenous Solutions (Colloids) Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Intravenous Solutions (Colloids) Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Intravenous Solutions (Colloids) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Intravenous Solutions (Colloids) Sales (K Units) by Region (2015-2020)
Table 5. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020)
Table 6. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Intravenous Solutions (Colloids) Revenue Share by Region (2015-2020)
Table 8. Global Intravenous Solutions (Colloids) Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Intravenous Solutions (Colloids) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Intravenous Solutions (Colloids) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Intravenous Solutions (Colloids) (K Units) of Key Companies (2015-2020)
Table 13. Global Intravenous Solutions (Colloids) Sales Share by Company (2015-2020)
Table 14. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Intravenous Solutions (Colloids) Revenue Share by Company (2015-2020)
Table 16. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions (Colloids) as of 2019)
Table 17. Global Intravenous Solutions (Colloids) Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Intravenous Solutions (Colloids) Manufacturing Sites and Area Served
Table 19. Manufacturers Intravenous Solutions (Colloids) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Intravenous Solutions (Colloids) Players
Table 22. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 23. Global Intravenous Solutions (Colloids) Sales Share by Type (2015-2020)
Table 24. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Intravenous Solutions (Colloids) Price (K Units) by Type (2015-2020)
Table 26. Global Intravenous Solutions (Colloids) Sales Share by Type (2021-2026)
Table 27. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Intravenous Solutions (Colloids) Revenue Share by Type (2021-2026)
Table 29. Global Intravenous Solutions (Colloids) Price (K Units) by Type (2021-2026)
Table 30. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020)
Table 31. Global Intravenous Solutions (Colloids) Sales Share by Application (2015-2020)
Table 32. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Intravenous Solutions (Colloids) Price (K Units) by Application (2015-2020)
Table 34. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2021-2026)
Table 35. Global Intravenous Solutions (Colloids) Sales Share by Application (2021-2026)
Table 36. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Intravenous Solutions (Colloids) Revenue Share by Application (2021-2026)
Table 38. Global Intravenous Solutions (Colloids) Price (K Units) by Application (2021-2026)
Table 39. United States Intravenous Solutions (Colloids) Sales (K Units) by Company (2015-2020)
Table 40. United States Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
Table 41. United States Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 42. United States Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 43. United States Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020)
Table 44. United States Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
Table 45. Europe Intravenous Solutions (Colloids) Sales (K Units) by Company (2015-2020)
Table 46. Europe Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
Table 47. Europe Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 48. Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 49. Europe Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020)
Table 50. Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 51. China Intravenous Solutions (Colloids) Sales (K Units) by Company (2015-2020)
Table 52. China Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
Table 53. China Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 54. China Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 55. China Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020)
Table 56. China Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
Table 57. Japan Intravenous Solutions (Colloids) Sales (K Units) by Company (2015-2020)
Table 58. Japan Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
Table 59. Japan Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 60. Japan Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 61. Japan Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020)
Table 62. Japan Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Intravenous Solutions (Colloids) Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
Table 69. India Intravenous Solutions (Colloids) Sales (K Units) by Company (2015-2020)
Table 70. India Intravenous Solutions (Colloids) Sales Market Share by Company (2015-2020)
Table 71. India Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020)
Table 72. India Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
Table 73. India Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020)
Table 74. India Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
Table 75. ICU Medical Inc. Corporation Information
Table 76. ICU Medical Inc. Description and Business Overview
Table 77. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. ICU Medical Inc. Intravenous Solutions (Colloids) Product
Table 79. ICU Medical Inc. Recent Development
Table 80. B. Braun Melsungen AG Corporation Information
Table 81. B. Braun Melsungen AG Description and Business Overview
Table 82. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product
Table 84. B. Braun Melsungen AG Recent Development
Table 85. Fresenius Kabi AG Corporation Information
Table 86. Fresenius Kabi AG Description and Business Overview
Table 87. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Fresenius Kabi AG Intravenous Solutions (Colloids) Product
Table 89. Fresenius Kabi AG Recent Development
Table 90. Baxter Corporation Information
Table 91. Baxter Description and Business Overview
Table 92. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Baxter Intravenous Solutions (Colloids) Product
Table 94. Baxter Recent Development
Table 95. Amanta Healthcare Corporation Information
Table 96. Amanta Healthcare Description and Business Overview
Table 97. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Amanta Healthcare Intravenous Solutions (Colloids) Product
Table 99. Amanta Healthcare Recent Development
Table 100. Terumo Medical Corporation Corporation Information
Table 101. Terumo Medical Corporation Description and Business Overview
Table 102. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Terumo Medical Corporation Intravenous Solutions (Colloids) Product
Table 104. Terumo Medical Corporation Recent Development
Table 105. Grifols S.A. Corporation Information
Table 106. Grifols S.A. Description and Business Overview
Table 107. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Grifols S.A. Intravenous Solutions (Colloids) Product
Table 109. Grifols S.A. Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Intravenous Solutions (Colloids) Distributors List
Table 113. Intravenous Solutions (Colloids) Customers List
Table 114. Intravenous Solutions (Colloids) Market Key Trends
Table 115. Intravenous Solutions (Colloids) Key Opportunities and Drivers
Table 116. Intravenous Solutions (Colloids) Market Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Solutions (Colloids) Product Picture
Figure 2. Global Intravenous Solutions (Colloids) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Intravenous Solutions (Colloids) Market Share by Application in 2020 & 2026
Figure 6. Hospital & Clinics Examples
Figure 7. Ambulatory Examples
Figure 8. Home Care Examples
Figure 9. Global Intravenous Solutions (Colloids) Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Intravenous Solutions (Colloids) Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Intravenous Solutions (Colloids) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Intravenous Solutions (Colloids) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Intravenous Solutions (Colloids) Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Intravenous Solutions (Colloids) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Intravenous Solutions (Colloids) Players Market Share by Revenue in Intravenous Solutions (Colloids) 2015 & 2019
Figure 27. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Intravenous Solutions (Colloids) Revenue Share by Type (2015-2020)
Figure 29. Global Intravenous Solutions (Colloids) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Intravenous Solutions (Colloids) Revenue Share by Application (2015-2020)
Figure 31. Global Intravenous Solutions (Colloids) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 33. United States Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 34. Europe Intravenous Solutions (Colloids) Sales Market Share by Company in 2019
Figure 35. Europe Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 36. Europe Intravenous Solutions (Colloids) Sales Market Share by Application in 2019
Figure 37. China Intravenous Solutions (Colloids) Sales Market Share by Company in 2019
Figure 38. China Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 39. China Intravenous Solutions (Colloids) Sales Market Share by Application in 2019
Figure 40. Japan Intravenous Solutions (Colloids) Sales Market Share by Company in 2019
Figure 41. Japan Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 42. Japan Intravenous Solutions (Colloids) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Application in 2019
Figure 46. India Intravenous Solutions (Colloids) Sales Market Share by Company in 2019
Figure 47. India Intravenous Solutions (Colloids) Sales Market Share by Type in 2019
Figure 48. India Intravenous Solutions (Colloids) Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Intravenous Solutions (Colloids)
Figure 51. Manufacturing Process Analysis of Intravenous Solutions (Colloids)
Figure 52. Intravenous Solutions (Colloids) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed